Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

NCT ID: NCT06569771

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-11

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being carried out in the context of rehabilitation after stroke, where persistent upper limb weakness is a major challenge. It aims to explore the relationship between observed function and patients' perceived participation in use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Limb Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients suffering from motor impairment of the upper limbs following a stroke

Voluntary patients suffering from motor impairment of the upper limbs following a stroke

Functional assessments

Intervention Type DIAGNOSTIC_TEST

* Computer Adaptive Test for Fugl-Meyer (CAT-FM)
* Action Research Arm Test (ARAT)
* Measurement of Functional Independence
* Star cancellation test
* Stroke Impact Scale
* ACTIVLIM (assesses the ability to perform activities of daily living requiring the use of the upper limbs)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional assessments

* Computer Adaptive Test for Fugl-Meyer (CAT-FM)
* Action Research Arm Test (ARAT)
* Measurement of Functional Independence
* Star cancellation test
* Stroke Impact Scale
* ACTIVLIM (assesses the ability to perform activities of daily living requiring the use of the upper limbs)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First stroke as defined by the World Health Organization.
* Upper limb paresis with a NIHSS National Institutes of Health Stroke Scale score \> or = 1/4 for upper limb motor function

Exclusion Criteria

* Life expectancy \<12 months
* Inability to understand French.
* Pre-existing severe multiple disability affecting arm function.
* Presence of pre-existing central neurological pathologies.
* Mini-Mental State Examination \< 21
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Grand Hôpital de Charleroi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maxime Valet, MD

Role: PRINCIPAL_INVESTIGATOR

Grand Hôpital de Charleroi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Grand Hôpital de Charleroi

Charleroi, Hainaut, Belgium

Site Status RECRUITING

CHU HELORA site Kennedy

Mons, Hainaut, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maxime VALET, MD

Role: CONTACT

0032 60 ext. 119424

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maxime VALET, MSc

Role: primary

0032 60 ext. 119424

Benjamin BOLLENS, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Perception Valet M 2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.